Safety and Efficacy of Immunomodulator Drug Thalidomide in Multi-transfused Thalassemia Patients
NCT06888232
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
121
Enrollment
OTHER
Sponsor class
Conditions
Thalassemia
Interventions
DRUG:
Thalidomide
Sponsor
Muhammad Aamir Latif